Social Media Ideas for Ilmn

Analyst Report: Illumina Inc

Imunon, Inc. (IMNN) Presents at Life Sciences Virtual Investor Forum - Slideshow

What This Immunome Sale Means a Day Before a Big FDA Milestone

Barchas maintains 211,763 residual shares through direct and indirect holdings following execution under a Rule 10b5-1 trading plan adopted in March 2026.

​Breakthrough Science Meets Market Skepticism: Insight Molecular Diagnostics Inc. (IMDX)’s Defining Moment

Ionis Pharmaceuticals, Inc. (IONS) Presents at National Lipid Association (NLA) 2026 Scientific Sessions - Slideshow

Illumina Announces MRD Kit Ahead of ASCO Meeting

Ahead of ASCO 2026, Illumina unveiled an early-access MRD research kit using whole-genome sequencing and DRAGEN analysis, enabling highly sensitive cancer monitoring workflows on N...

IMU Biosciences nabs $53M funding round to ‘decode’ the immune system

British medtech startup IMU Biosciences has landed a £40 million ($53 million) series A as it looks to move immune system analysis from analog to “high definition.”

Form 4 Lyell Immunopharma Inc For: 15 June

<![CDATA[Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive ]]>

Ionis Pharmaceuticals, Inc. (IONS) Presents at American Diabetes Association (ADA) 86th Scientific Sessions - Slideshow

Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach

A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer

This biotechnology firm leverages machine learning to design novel protein therapeutics targeting unmet medical needs.

IGC Pharma (NYSE: IGC) Showcasing 7 AI Breakthroughs Advancing Alzheimer’s Drug Discovery at AAIC 2026

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

SHENZHEN, China, July 5, 2026 /PRNewswire/ -- MGI's subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, today announced the launch of two...

This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%

GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions.

<![CDATA[Ascidian and Eli Lilly Enter $1.9 Billion Global Research Collaboration to Develop RNA Exon Editors]]>

StockWatch: Positive Phase III Data Sells Investors on Intellia

The data was strong enough for Intellia to continue the rolling Biologics License Application (BLA) submission that it began in April. The company expects to complete the BLA filin...

Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory Disease - Slidesho...